Human Embryo Gene Editing Gets a Road Map—Not a Green Light
After the 2018 “Crispr baby” scandal, a global commission assessed the technology and set strict criteria for moving it toward clinical trials.
After the 2018 “Crispr baby” scandal, a global commission assessed the technology and set strict criteria for moving it toward clinical trials.